ARA290, a small non-hematopoietic peptide derived from erythropoietin, prolongs healthspan and attenuates age-associated declines in cardiac function

被引：0

作者：

Nanavati, Alay ^{[1
]}

Moen, Jack ^{[1
]}

Axsom, Jessie ^{[1
]}

Krawczyk, Melissa ^{[1
]}

Petrashevskaya, Natalia ^{[1
]}

Beyman, Max ^{[1
]}

Ramirez, Christopher ^{[1
]}

Alfaras, Irene ^{[1
]}

Mitchell, Sarah ^{[1
]}

Bernier, Michel ^{[1
]}

Morrell, Christopher ^{[1
]}

Sollott, Steven ^{[1
]}

Juhaszova, Magdalena ^{[1
]}

deCabo, Rafael ^{[1
]}

Lakatta, Edward ^{[1
]}

机构：

[1] NIA, Baltimore, MD 21224 USA

来源：

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2018年 / 124卷

关键词：

D O I：

10.1016/j.yjmcc.2018.07.016

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P1-08

引用

页码：85 / 86

页数：2

共 5 条

[1] ARA290, A Small Non-Hematopoietic Peptide Derived From Erythropoietin, Prolongs Healthspan And Attenuates Age-Associated Declines In The Heart's Structure And Function
Nanavati, Alay
Moen, Jack
Axsom, Jessie
Krawczyk, Melissa
Petrashevskaya, Natalia
Beyman, Max
Ramirez, Christopher
Alfaras, Irene
Mitchell, Sarah
Bernier, Michel
Morrell, Christopher
Sollott, Steven
Juhaszova, Magdalena
deCabo, Rafael
Lakatta, Edward
FASEB JOURNAL, 2018, 32 (01):
[2] A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan
Winicki, Nolan M. M.
Nanavati, Alay P. P.
Morrell, Christopher H. H.
Moen, Jack M. M.
Axsom, Jessie E. E.
Krawczyk, Melissa
Petrashevskaya, Natalia N. N.
Beyman, Max G. G.
Ramirez, Christopher
Alfaras, Irene
Mitchell, Sarah J. J.
Juhaszova, Magdalena
Riordon, Daniel R. R.
Wang, Mingyi
Zhang, Jing
Cerami, Anthony
Brines, Michael
Sollott, Steven J. J.
De Cabo, Rafael
Lakatta, Edward G. G.
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 9
[3] SAFETY AND EFFICACY OF ARA290, A NON-HEMATOPOIETIC ERYTHROPOIETIN DERIVED PEPTIDE, IN A 4 WEEKS PHASE II OPEN LABEL TRIAL IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
Van Den Broek, M.
Allaart, C. F.
Brines, M.
Cerami, A.
Huizinga, T. W.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 620 - 620
[4] An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress
Shokrzadeh, Mohammad
Etebari, Mahmoud
Ghassemi-Barghi, Nasrin
TOXICOLOGY IN VITRO, 2020, 66
[5] ARA290, a small peptide non-erythropoietic Erythropoietin derivative, ameliorates heart functional deterioration in a chronic cardiac stress model
Gime, Suri
Winicki, Nolan
Ahmet, Ismayil
Morrell, Christopher
Lakatta, Edward
CIRCULATION RESEARCH, 2024, 135

← 1 →